Nishant C Saxena has bought CRBP on 2 days since Jun 2026

Nishant C. Saxena is the Chief Business Officer of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), where he oversees corporate strategy, business development, and capital markets activities as the company advances its clinical-stage pipeline.( He joined Corbus in May 2026 and is reported as a corporate insider, holding shares of Corbus common stock as disclosed in his initial Form 3 and related beneficial ownership filings.( Saxena has over 20 years of experience in finance, strategy, capital markets, mergers and acquisitions, and corporate development.(

Before joining Corbus, Saxena served as Chief Financial Officer of Jeune Aesthetics, Inc., a wholly owned subsidiary of Krystal Biotech, Inc.( Previously, he spent more than 15 years at Evercore, most recently as a Managing Director in the healthcare group, where he advised on transactions totaling over $500 billion in aggregate value, including mergers and acquisitions, private placements, IPOs, follow-on offerings, partnerships, and structured financings.( Earlier in his career, he held roles of increasing responsibility in private equity, venture capital, and investment advisory firms.( Saxena holds a B.S. in Economics and an MBA from the Wharton School of the University of Pennsylvania.(

Written by Perplexity from public sources.